Bepridil

General Toxicity Notes
Headache, edema, flushing, dizziness.
Excreted Unchanged %
<1
Half-Life (Normalesrd) Hours
24-48/24-48
Plasma Protein Binding %
No data
Volume Of Distribution L/Kg
No data
Dose For Normal Renal Function
No data
Adjustment For Renal Failure Gfr, Ml/Min >50 [Recommended Level]
No data
Adjustment For Renal Failure Gfr, Ml/Min 10-50 [Recommended Level]
No data
Adjustment For Renal Failure Gfr, Ml/Min <10 [Recommended Level]
No data
Supplement For Dialysis [Recommendation Level]: Ihd
IHD: None
Supplement For Dialysis [Recommendation Level]: Pd
PD: None
Supplement For Dialysis [Recommendation Level]: Crrt
CRRT: Dose for GFR 10-50, titrate, [D]
References
Hollingshead LM, Faulds D, Fitton A. Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris. Drugs. 1992; 44: 835-57. [PMID: 1280569]
Toxicity Notes
Weak vasodilator and antihypertensive.